StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Myriad Genetics (MYGN) PT Raised to $26 at Morgan Stanley
November 8, 2017 8:43 AM
Morgan Stanley raised its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Myriad Genetics (MYGN) Tops Q1 EPS by 5c, Beats on Revenues; Offers FY18 EPS Guidance
November 7, 2017 4:31 PM
Myriad Genetics Reports Fiscal First-Quarter 2018 Financial Results
November 7, 2017 4:06 PM